Renevo makes second attempt at floatation

The improving fortunes of the UK biotech industry were highlighted today when Renovo launched its second attempt to list on the stock market.

Renevo makes second attempt at floatation

The improving fortunes of the UK biotech industry were highlighted today when Renovo launched its second attempt to list on the stock market.

Renovo, which develops drugs that prevent and reduce scarring on the skin and inside the body, aims to raise £40m (€58m) by offering shares to institutional investors.

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited